CME Group Inc (CME) Director Sells $1,137,194.00 in Stock

CME Group Inc (NASDAQ:CME) Director Leo Melamed sold 7,300 shares of the firm’s stock in a transaction dated Monday, February 5th. The stock was sold at an average price of $155.78, for a total transaction of $1,137,194.00. Following the transaction, the director now directly owns 10,537 shares in the company, valued at $1,641,453.86. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

CME Group Inc (NASDAQ:CME) opened at $156.85 on Friday. The company has a quick ratio of 1.05, a current ratio of 1.03 and a debt-to-equity ratio of 0.10. CME Group Inc has a 1-year low of $114.82 and a 1-year high of $163.00. The company has a market cap of $53,370.00, a PE ratio of 13.14, a price-to-earnings-growth ratio of 2.09 and a beta of 0.64.

CME Group (NASDAQ:CME) last released its earnings results on Thursday, February 1st. The financial services provider reported $1.12 EPS for the quarter, beating the consensus estimate of $1.10 by $0.02. CME Group had a net margin of 111.49% and a return on equity of 7.68%. The firm had revenue of $900.00 million for the quarter, compared to analyst estimates of $886.85 million. During the same period last year, the firm earned $1.14 EPS. The business’s quarterly revenue was down 1.4% compared to the same quarter last year. equities research analysts predict that CME Group Inc will post 6.26 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Monday, March 26th. Shareholders of record on Friday, March 9th will be issued a $0.70 dividend. This is a positive change from CME Group’s previous quarterly dividend of $0.66. This represents a $2.80 annualized dividend and a yield of 1.79%. The ex-dividend date of this dividend is Thursday, March 8th. CME Group’s dividend payout ratio (DPR) is currently 22.11%.

A number of hedge funds have recently added to or reduced their stakes in CME. Quadrant Capital Group LLC increased its holdings in CME Group by 13.6% in the 2nd quarter. Quadrant Capital Group LLC now owns 944 shares of the financial services provider’s stock valued at $111,000 after buying an additional 113 shares during the period. Valeo Financial Advisors LLC acquired a new stake in shares of CME Group in the 3rd quarter valued at approximately $124,000. People s United Financial Inc. boosted its stake in shares of CME Group by 11.5% in the 2nd quarter. People s United Financial Inc. now owns 1,063 shares of the financial services provider’s stock valued at $133,000 after purchasing an additional 110 shares in the last quarter. Bank of Nova Scotia Trust Co. acquired a new stake in shares of CME Group in the 3rd quarter valued at approximately $165,000. Finally, SeaCrest Wealth Management LLC acquired a new stake in shares of CME Group in the 4th quarter valued at approximately $203,000. 82.65% of the stock is currently owned by hedge funds and other institutional investors.

A number of research firms recently commented on CME. BidaskClub raised shares of CME Group from a “buy” rating to a “strong-buy” rating in a research report on Saturday. Goldman Sachs Group raised shares of CME Group from a “neutral” rating to a “buy” rating and set a $180.00 price target on the stock in a research report on Wednesday. Bank of America raised their price target on shares of CME Group from $173.00 to $175.00 and gave the stock a “buy” rating in a research report on Friday, February 2nd. Barclays raised their price target on shares of CME Group from $170.00 to $175.00 and gave the stock an “overweight” rating in a research report on Friday, February 2nd. Finally, Sandler O’Neill reaffirmed a “buy” rating and set a $175.00 price target on shares of CME Group in a research report on Friday, February 2nd. Three research analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has given a strong buy rating to the stock. CME Group presently has an average rating of “Buy” and an average target price of $157.00.

WARNING: This piece of content was originally published by Community Financial News and is the sole property of of Community Financial News. If you are accessing this piece of content on another domain, it was stolen and reposted in violation of United States and international copyright laws. The original version of this piece of content can be read at https://www.com-unik.info/2018/02/10/cme-group-inc-cme-director-sells-1137194-00-in-stock.html.

CME Group Company Profile

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Insider Buying and Selling by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit